Fabrication and characterization of DNA-loaded zein nanospheres

Journal of Nanobiotechnology

Volumn 10, Issue , 2012, Pages

  Regier, Mary C ^a   Taylor, Jessica D ^a   Borcyk, Tyler ^a   Yang, Yiqi ^a   Pannier, Angela K ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

DNA; Gene delivery; Intramuscular injection; Nanoparticle; Nonviral; Oral delivery; Zein

Indexed keywords

CANDIDATE MATERIALS; CELLULAR ASSOCIATION; CELLULAR INTERNALIZATION; DNA INTEGRITY; DNA-ENCAPSULATION; ENCAPSULATED COMPOUNDS; FABRICATION TECHNIQUE; GENE DELIVERY; HYDROPHILIC COMPOUNDS; HYDROPHOBIC NATURE; HYDROPHOBIC PROTEIN; INTRAMUSCULAR INJECTIONS; MAXIMUM LOADING; NATURAL BIOMATERIALS; NONVIRAL; ORAL DELIVERY; PHYSIOLOGICAL CONDITION; PLASMID DNA; POTENTIAL TOOL; SUSTAINED RELEASE; THERAPEUTIC COMPOUNDS; TISSUE ENGINEERING SCAFFOLD;

AUTOMOBILE MANUFACTURE; BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; BIOMOLECULES; DRUG DELIVERY; ENCAPSULATION; FABRICATION; GENE TRANSFER; HYDROPHOBICITY; NANOPARTICLES; NANOSPHERES; SCAFFOLDS (BIOLOGY); ZEIN;

DNA;

DEOXYRIBONUCLEASE; DNA; MACROGOL; SOLVENT; ZEIN;

ARTICLE; BIOCOMPATIBILITY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; ENZYME DEGRADATION; GENE TARGETING; HYDROPHILICITY; HYDROPHOBICITY; NANOTECHNOLOGY; NONHUMAN; PLASMID; TEMPERATURE; TISSUE ENGINEERING;

CACO-2 CELLS; CELL SURVIVAL; DEOXYRIBONUCLEASE I; DNA; HEK293 CELLS; HUMANS; NANOSPHERES; PARTICLE SIZE; SOLVENTS; TEMPERATURE; ZEIN;

ZEA MAYS;

EID: 84870210050     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/1477-3155-10-44     Document Type: Article

References (69)

1. Niidome T, Huang L. Gene therapy progress and prospects: Nonviral vectors. Gene Ther 2002, 9:1647-1652. 10.1038/sj.gt.3301923, 12457277.
2. Donnelly JJ, Ulmer JB, Shiver JW, Liu MA. DNA vaccines. Annu Rev Immunol 1997, 15:617-648. 10.1146/annurev.immunol.15.1.617, 9143702.
3. Pannier AK, Ariazi EA, Bellis AD, Bengali Z, Jordan VC, Shea LD. Bioluminescence imaging for assessment and normalization in transfected cell arrays. Biotechnol Bioeng 2007, 98:486-497. 10.1002/bit.21477, 2648395, 17486653.
4. Shea LD, Smiley E, Bonadio J, Mooney DJ. DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol 1999, 17:551-554. 10.1038/9853, 10385318.
5. Mintzer MA, Simanek EE. Nonviral vectors for gene delivery. Chem Rev 2009, 109:259-302. 10.1021/cr800409e, 19053809.
6. Li S, Huang L. Nonviral gene therapy: promises and challenges. Gene Ther 2000, 7:31-34. 10.1038/sj.gt.3301110, 10680013.
7. Agarwal A, Mallapragada SK. Synthetic sustained gene delivery systems. Curr Top Med Chem 2008, 8:311-330. 10.2174/156802608783790965, 18393894.
8. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003, 55:329-347. 10.1016/S0169-409X(02)00228-4, 12628320.
9. Bhavsar MD, Amiji MM. Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS). J Control Release 2007, 119:339-348. 10.1016/j.jconrel.2007.03.006, 17475358.
10. Page DT, Cudmore S. Innovations in oral gene delivery: challenges and potentials. Drug Discov Today 2001, 6:92-101. 10.1016/S1359-6446(00)01600-7, 11166257.
11. Rothman S, Tseng H, Goldfine I. Oral gene therapy: A novel method for the manufacture and delivery of protein drugs. Diabetes Technol Ther 2005, 7:549-557. 10.1089/dia.2005.7.549, 15929688.
12. Jones DH, Corris S, McDonald S, Clegg JC, Farrar GH. Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine 1997, 15:814-817. 10.1016/S0264-410X(96)00266-6, 9234522.
13. Loretz B, Foger F, Werle M, Bernkop-Schnurch A. Oral gene delivery: Strategies to improve stability of pDNA towards intestinal digestion. J Drug Target 2006, 14:311-319. 10.1080/10611860600823766, 16882551.
14. Chen H, Langer R. Oral particulate delivery: status and future trends. Adv Drug Deliv Rev 1998, 24:339-350.
15. Roy K, Mao H-Q, Huang S-K, Leong KW. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999, 5:387-391. 10.1038/7385, 10202926.
16. Bowman K, Sarkar R, Raut S, Leong KW. Gene transfer to hemophilia A mice via oral delivery of FVIII-chitosan nanoparticles. J Control Release 2008, 132:252-259. 10.1016/j.jconrel.2008.06.019, 2754405, 18634839.
17. Jones DH, Clegg JC, Farrar GH. Oral delivery of micro-encapsulated DNA vaccines. Dev Biol Stand 1998, 92:149-155.
18. He X-W, Wang F, Jiang L, Li J, Liu S-K, Xiao Z-Y, Jin X-Q, Zhang Y-N, He Y, Li K, et al. Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg. J Gen Virol 2005, 86:601-610. 10.1099/vir.0.80575-0, 15722520.
19. O'Hagan DT, Singh M, Ulmer JB. Microparticles for the delivery of DNA vaccines. Immunol Rev 2004, 199:191-200. 10.1111/j.0105-2896.2004.00153.x, 15233735.
20. Tripathy SK, Svensson EC, Black HB, Goldwasser E, Margalith M, Hobart PM, Leiden JM. Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proc Natl Acad Sci USA 1996, 93:10876-10880. 10.1073/pnas.93.20.10876, 38250, 8855275.
21. Shyu K-G, Manor O, Magner M, Yancopoulos GD, Isner JM. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation 1998, 98:2081-2087. 10.1161/01.CIR.98.19.2081, 9808608.
22. Wang J, Zhang P-C, Mao H-Q, Leong KW. Enhanced gene expression in mouse muscle by sustained release of plasmid DNA using PPE-EA as a carrier. Gene Ther 2002, 9:1254-1261. 10.1038/sj.gt.3301794, 12215893.
23. Dang JM, Leong KW. Natural polymers for gene delivery and tissue engineering. Adv Drug Deliv Rev 2006, 58:487-499. 10.1016/j.addr.2006.03.001, 16762443.
24. Malafaya PB, Silva GA, Reis RL. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv Drug Deliv Rev 2007, 59:207-233. 10.1016/j.addr.2007.03.012, 17482309.
25. Yannas IV. Natural Materials. Biomaterial Science: An Introduction to Materials in Medicine 2004, San Diego: Academic Press, Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, 2.
26. Czaja WK, Young DJ, Kawecki M, Brown RM. The future prospects of microbial cellulose in biomedical applications. Biomacromolecules 2007, 8:1-12. 10.1021/bm060620d, 17206781.
27. Malafaya PB, Stappers F, Reis RL. Starch-based microspheres produced by emulsion crosslinking with a potential media dependent responsive behavior to be used as drug delivery carriers. J Mater Sci Mater Med 2006, 17:371-377. 10.1007/s10856-006-8240-z, 16617416.
28. Reddy N, Yang Y. Potential of plant proteins for medical applications. Trends Biotechnol 2011, 29:490-498. 10.1016/j.tibtech.2011.05.003, 21665302.
29. Esen A. A proposed nomenclature for the alcohol-soluble proteins (zeins) of maize (Zea mays L.). Journal of Cereal Science 1987, 5:117-128.
30. Geraghty D, Peifer MA, Rubenstein I, Messing J. The primary structure of a plant storage protein: zein. Nucleic Acids Res 1981, 9:5163-5174. 10.1093/nar/9.19.5163, 327507, 6895552.
31. Cabra V, Arregun R, Galvez A, Quirasco M, Vazquez-Duhalt R, Farres A. Characterization of 19 kDa alpha-zein of high purity. J Agric Food Chem 2005, 53.
32. Hurtado-Lopez P, Murdan S. Zein microspheres as drug/antigen carriers: A study of their degradation and erosion, in the presence and absence of enzymes. J Microencapsul 2006, 23:303-314. 10.1080/02652040500444149, 16801242.
33. Pomes AF. Zein. Encyclopedia of Polymer Science and Technology: plastics, resins, rubbers, fibers vol. 15 1971, 125-132. New York: Interscience Publishers, Mark HF, Gaylord NG, Bikales NM.
34. Padua GW, Wang Q. Controlled Self-Organization of Zein Nanostructures for Encapsulation of Food Ingredients. Micro/Nanoencapsulation of Active Food Ingredients 2009, 143-156. Washington D.C.: American Chemical Society, Huang Q, Given P, Qian M.
35. Wang Q, Wang JF, Geil PH, Padua GW. Zein adsorption to hydrophilic and hydrophobic surfaces investigated by surface plasmon resonance. Biomacromolecules 2004, 5:1356-1361. 10.1021/bm049965r, 15244451.
36. Deo N, Jockusch S, Turro NJ, Somasundaran P. Surfactant interactions with zein protein. Langmuir 2003, 19:5083-5088.
37. Parris N, Cooke PH, Hicks KB. Encapsulation of essential oils in zein nanospherical particles. J Agric Food Chem 2005, 53:4788-4792. 10.1021/jf040492p, 15941317.
38. Gong S-J, Sun S-X, Sun Q-S, Wang J-Y, Liu X-M, Liu G-Y. Tablets based on compressed zein microspheres for sustained oral administration: Design, pharmacokinetics and clinical study. J Biomater Appl 2010, 00:1-14.
39. DiBiase MD, Morrel EM. Oral Delivery of Microencapsulated Proteins. Protein Delivery: Physical Systems. Volume 10 1997, New York: Plenum Press, Sanders LM, Hendren RW, [Borchardt RT (Series Editor): Pharmaceutical Biotechnology].
40. Sun Q-S, Dong J, Lin Z-X, Yang B, Wang J-Y. Comparison of cytocompatibility of zein film and other biomaterials and its degradability in vitro. Biopolymers 2005, 78:268-274. 10.1002/bip.20298, 15898117.
41. Fernandez-Carneado J, Kogan MJ, Castel S, Giralt E. Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein. Angew Chem Int Ed Engl 2004, 43:1811-1814. 10.1002/anie.200352540, 15054781.
42. Gander B, Blanco-Prieto MJ, Thomasin C, Wandrey C, Hunkeler D. Coacervation and Phase Separation. Encyclopedia of Pharmaceutical Technology, vol. 1 2006, New York: Informa.
43. Madan PL. Microencapsulation I. Phase separation or coacervation. Drug Dev Ind Pharm 1978, 4:95-116.
44. Arshady R. Microspheres and microcapsules, a survey of manufacturing techniques Part II: Coacervation. Polym Eng Sci 1990, 30:905-914.
45. Hurtado-Lopez P, Murdan S. Formulation and characterisation of zein microspheres as delivery vehicles. J Drug Deliv Sci Tech 2005, 15:267-272.
46. Suzuki T, Sato E, Matsuda T, Tada H, Unno K, Kato T. Preparation of zein microspheres conjugated with antitumor drugs available for selective cancer chemotherapy and development of a simple colorimetric determination of drugs in microspheres. Chem Pharm Bull 1989, 37:1051-1054. 10.1248/cpb.37.1051, 2766407.
47. Wang H-J, Lin Z-X, Liu X-M, Sheng S-Y, Wang J-Y. Heparin-loaded zein microsphere film and hemocompatibility. J Control Release 2005, 105:120-131. 10.1016/j.jconrel.2005.03.014, 15893840.
48. Fu J-X, Wang H-J, Zhou Y-Q, Wang J-Y. Antibacterial activity of ciprofloacin-loaded zein microsphere films. Material Science and Engineering C 2009, 29:1161-1166.
49. Liu X, Sun Q, Wang H, Zhang L, Wang J. Microspheres of corn protein, zein for an invermectin drug delivery system. Biomaterials 2005, 26:109-115. 10.1016/j.biomaterials.2004.02.013, 15193886.
50. Muthuselvi L, Dhathathreyan A. Simple coacervates of zein to encapsulate gitoxin. Colloids and Surfaces B: Bioinformatics 2006, 51:39-43.
51. Zhong Q, Jin M. Zein nanoparticles produced by liquid-liquid dispersion. Food Hydrocolloids 2009, 23:2380-2387.
52. Jiang Q, Yang Y. Water-stable electrospun zein fibers for potential drug delivery. J Biomater Sci Polym Ed 2011, 22:1393-1408.
53. Gennadios A, Weller CL. Moisture adsorption by grain protein films. Trans ASAE 1994, 37:535-539.
54. Everett DH. Basic Principles of Colloid Science 1988, London: Royal Society of Chemistry.
55. O'Hagan DT. The intestinal uptake of particles and the implications for drug and antigen delivery. J Anat 1996, 189:477-482. 1167686, 8982819.
56. Clark MA, Jepson MA, Hirst BH. Exploiting M cells for drug and vaccine delivery. Adv Drug Deliv Rev 2001, 50:81-106. 10.1016/S0169-409X(01)00149-1, 11489335.
57. Hombach J, Bernkop-Schnurch A. Handbook of experimental pharmacology. Handb Exp Pharmacol 2010, 197:251-266. 10.1007/978-3-642-00477-3_9, 20217533.
58. Astete CE, Sabliov CM. Synthesis and characterization of PLGA nanoparticles. J Biomater Sci Polym Ed 2006, 17:247-289. 10.1163/156856206775997322, 16689015.
59. Mao H-Q, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, August JT, Leong KW. Chitosan-DNA nanoparticles as gene carriers: synthesis characterization and transfection efficiency. J Control Release 2001, 70:399-421. 10.1016/S0168-3659(00)00361-8, 11182210.
60. Masotti A, Bordi F, Ortaggi G, Marino F, Palocci C. A novel method to obtain chitosan/DNA nanospheres and a study of their release properties. Nanotechnology 2008, 19:055302. 10.1088/0957-4484/19/05/055302, 21817607.
61. Jang J-H, Shea LD. Controllable delivery of non-viral DNA from porous scaffolds. J Control Release 2003, 86:157-168. 10.1016/S0168-3659(02)00369-3, 12490381.
62. Luo Y, Zhang B, Whent M, Yu L, Wang Q. Preparation and characterization of zein/chitosan complex for encapsulation of α-tocopherol, and its in vitro controlled release study. Colloids Surf B Biointerfaces 2011, 85:145-152. 10.1016/j.colsurfb.2011.02.020, 21440424.
63. Podaralla S, Perumal O. Preparation of Zein Nanoparticles by pH Controlled Nanoprecipitation. J Biomed Nanotechnol 2010, 6:312-317. 10.1166/jbn.2010.1137, 21323103.
64. Lawton JW. Zein: A History of Processing and Use. Cereal Chemistry 2002, 79:1-18.
65. Gong S, Wang H, Sun Q-S, Xue S-T, Wang J-Y. Mechanical properties and in vitro biocompatibility of porous zein scaffolds. Biomaterials 2006, 27:3793-3799. 10.1016/j.biomaterials.2006.02.019, 16527348.
66. Mathiowitz E, Bernstein H, Morrel E, Schwaller K. Method for producing protein microspheres. Patent US ed., vol. 5,271,961; 1993.
67. Gan Q, Wang T, Cochrane C, McCarron P. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B Biointerfaces 2005, 44:65-73. 10.1016/j.colsurfb.2005.06.001, 16024239.
68. Demetriades K, Coupland JN, McClements DJ. Physical Properties of Whey Protein Stabilized Emulsions as Related to pH and NaCl. J Food Sci 1997, 62:342-347.
69. Lai LF, Guo HX. Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting. Int J Pharm 2011, 404:317-323. 10.1016/j.ijpharm.2010.11.025, 21094232.